Senti Biosciences Holdings, Inc.
SNTI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001854270
No open-market purchases or sales by Senti Biosciences Holdings, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $6.37M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Senti Biosciences Holdings, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +2 vs. Q4 2023
- Shares held
- 11.0M
- −466.9K (−4.1%) vs. Q4 2023
- Total value
- $4.15M
- −$3.42M (−45.2%) vs. Q4 2023
- New holders
- 7
- 4 more added
- Sold out
- 5
- 3 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SNTI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $6.37M |
| Q1 2026 | 16 | $4.58M |
| Q4 2025 | 15 | $5.84M |
| Q3 2025 | 16 | $8.27M |
| Q2 2025 | 15 | $14.2M |
| Q1 2025 | 16 | $19.9M |
| Q4 2024 | 16 | $3.23M |
| Q3 2024 | 14 | $2.41M |
| Q2 2024 | 20 | $2.17M |
| Q1 2024 | 27 | $4.15M |
| Q4 2023 | 25 | $7.56M |
| Q3 2023 | 26 | $5.02M |
| Q2 2023 | 28 | $7.64M |
| Q1 2023 | 24 | $14.3M |
| Q4 2022 | 26 | $16.6M |
| Q3 2022 | 23 | $27.8M |
| Q2 2022 | 20 | $22.1M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Senti Biosciences Holdings, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Toronto Dominion Bank | 37 | $14 | 0.00% | +37 | New |
| Comerica Bank | 48 | $18 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 202 | $76 | 0.00% | +3+1.5% | Added |
| Bank of America Corp | 241 | $91 | 0.00% | −5,000−95.4% | Reduced |
| UBS Group AG | 732 | $276 | 0.00% | +732 | New |
| Wolverine Asset Management LLC | 800 | $301 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,340 | $505 | 0.00% | +1,340 | New |
| Morgan Stanley | 1,600 | $603 | 0.00% | +1,600 | New |
| Tower Research Capital LLC (TRC) | 8,514 | $3.21K | 0.00% | +8,514 | New |
| Millennium Management LLC | 13,337 | $5.03K | 0.00% | −1,078−7.5% | Reduced |
| Harbour Investments, Inc. | 15,000 | $5.66K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 19,678 | $7.00K | 0.00% | +19,678 | New |
| Allen Operations LLC | 21,443 | $8.08K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 24,102 | $9.00K | 0.00% | +24,102 | New |
| Northern Trust Corp | 36,848 | $13.9K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 39,100 | $14.7K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 40,052 | $15.1K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 79,005 | $29.8K | 0.00% | +35,302+80.8% | Added |
| Two Sigma Investments, LP | 93,621 | $35.3K | 0.00% | +64,978+226.9% | Added |
| Bridgeway Capital Management, LLC | 145,000 | $54.7K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 245,590 | $92.6K | 0.00% | +7,184+3.0% | Added |
| Hongkou Capital LP | 310,533 | $117.1K | 1.37% | 00.0% | Unchanged |
| Intel Corp | 595,665 | $224.6K | 0.03% | 00.0% | Unchanged |
| Vanguard Group Inc | 707,052 | $266.6K | 0.00% | 00.0% | Unchanged |
| ARK Investment Management LLCSuperinvestorARK Invest | 1,630,922 | $615.0K | 0.00% | −338,938−17.2% | Reduced |
| 8VC GP I, LLC | 2,537,558 | $956.9K | 1.22% | 00.0% | Unchanged |
| NEA Management Company, LLC | 4,426,151 | $1.67M | 0.10% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 0 | $0 | 0.00% | −195,792−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −55,555−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −21,645−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −12,369−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −43−100.0% | Sold out |